Moduretic 5-50, Coaprovel(hydrochlorothiazide)
Accuretic, Aldactazide, Aldoril, Amturnide, Apresazide, Apresoline-esidrix, Atacand, Avalide, Benicar, Cam-ap-es, Capozide, CoAprovel, Copalia, Dafiro, Diovan, Dutoprol, Esimil, Exforge, H.r, Hydra-zide, Hydrap-es, Hydro-reserp, Hydro-ride, Hydro-serp, Hydropres, Hydroserpine (r), Hyzaar, Inderide, Inderide-, Karvezide, Kinzalkomb, Lopressor, Lotensin, Maxzide, Micardis, Microzide, Moduretic, Monopril-hct, Normozide, Oreticyl, PritorPlus, Rasilez, Rasitrio, Riprazo, Ser-a-gen, Ser-ap-es, Serpasil-esidrix, Sprimeo, Tekturna, Teveten, Timolide, Trandate, Tribenzor, Unipres, Uniretic, Vaseretic, Viskazide, Zestoretic, Ziac (hydrochlorothiazide) is a small molecule pharmaceutical. Hydrochlorothiazide was first approved as Moduretic 5-50 on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA. It has been approved in Europe to treat essential hypertension and hypertension. The pharmaceutical is active against solute carrier family 12 member 3.
Download report
Favorite
Novartis Pharmaceuticals
Top Prescription Drugs
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
cardiovascular diseases | D002318 |
signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Microzide (generic drugs available since 1982-01-01, discontinued: Esidrix, Hydro, Hydrodiuril, Oretic, Zide)
CombinationsAldactazide, Atacand, Avalide, Benicar, Diovan, Exforge, Hyzaar, Lopressor, Lotensin, Maxzide, Micardis, Tribenzor, Vaseretic, Zestoretic, Ziac (generic drugs available since 1982-01-01, discontinued: Accuretic, Aldoril, Aldoril d30, Aldoril d50, Amturnide, Apresazide, Apresoline-esidrix, Cam-ap-es, Capozide, Dutoprol, Dyazide, Esimil, H.r, Hydra-zide, Hydrap-es, Hydro-reserp, Hydro-ride, Hydro-serp, Hydropres, Hydroserpine (r), Inderide, Inderide-, Moduretic, Monopril-hct, Normozide, Oreticyl, Prinzide, Ser-a-gen, Ser-ap-es, Serpasil-esidrix, Tekturna, Teveten, Timolide, Trandate, Unipres, Uniretic, Viskazide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Aliskiren hemifumarate
+
Amlodipine besylate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
AMTURNIDE | Novartis | N-200045 DISCN | 2010-12-21 | 5 products |
Hide discontinued
Aliskiren hemifumarate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TEKTURNA HCT | Noden Pharma | N-022107 DISCN | 2008-01-18 | 4 products, RLD |
Hide discontinued
Amiloride hydrochloride
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MODURETIC 5-50 | Merck KGaA | N-018201 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Amlodipine besylate
+
Hydrochlorothiazide
+
Olmesartan medoxomil
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TRIBENZOR | Cosette Pharmaceuticals | N-200175 RX | 2010-07-23 | 5 products, RLD, RS |
Amlodipine besylate
+
Hydrochlorothiazide
+
Valsartan
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EXFORGE HCT | Novartis | N-022314 RX | 2009-04-30 | 5 products, RLD, RS |
Benazepril hydrochloride
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LOTENSIN HCT | Validus Pharmaceuticals | N-020033 RX | 1992-05-19 | 3 products, RLD |
Show 1 discontinued
Bisoprolol fumarate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZIAC | Teva | N-020186 RX | 1993-03-26 | 3 products, RLD |
Candesartan cilexetil
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ATACAND HCT | ANI PHARMS | N-021093 RX | 2000-09-05 | 3 products, RLD |
Captopril
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CAPOZIDE 25/15 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
CAPOZIDE 25/25 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
CAPOZIDE 50/25 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
CAPOZIDE 50/15 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
Hide discontinued
Deserpidine
+
Hydrochlorothiazide
Enalapril maleate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VASERETIC | Bausch Health Companies | N-019221 RX | 1986-10-31 | 2 products, RLD, RS |
Eprosartan mesylate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TEVETEN HCT | AbbVie | N-021268 DISCN | 2001-11-01 | 2 products |
Hide discontinued
Fosinopril sodium
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MONOPRIL-HCT | Bristol Myers Squibb | N-020286 DISCN | 1994-11-30 | 2 products, RLD |
Hide discontinued
Guanethidine monosulfate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ESIMIL | Novartis | N-013553 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydralazine hydrochloride
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
APRESOLINE-ESIDRIX | Novartis | N-012026 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydralazine hydrochloride
+
Hydrochlorothiazide
+
Reserpine
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SER-AP-ES | Novartis | N-012193 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MICROZIDE | Teva | N-020504 RX | 1996-12-27 | 1 products, RLD, RS |
Show 3 discontinued
Hydrochlorothiazide
+
Irbesartan
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
AVALIDE | Sanofi | N-020758 RX | 1997-09-30 | 2 products, RLD, RS |
Show 1 discontinued
Hydrochlorothiazide
+
Labetalol hydrochloride
Hydrochlorothiazide
+
Lisinopril
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZESTORETIC | Almatica Pharma | N-019888 RX | 1989-07-20 | 3 products, RLD, RS |
Show 1 discontinued
Hydrochlorothiazide
+
Losartan potassium
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
HYZAAR | Organon | N-020387 RX | 1995-04-28 | 3 products, RLD |
Hydrochlorothiazide
+
Methyldopa
Hydrochlorothiazide
+
Metoprolol succinate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DUTOPROL | Concordia Laboratories | N-021956 DISCN | 2006-08-28 | 3 products, RLD |
Hide discontinued
Hydrochlorothiazide
+
Metoprolol tartrate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LOPRESSOR HCT | Validus Pharmaceuticals | N-018303 RX | 1984-12-31 | 1 products, RLD |
Show 1 discontinued
Hydrochlorothiazide
+
Moexipril hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
UNIRETIC | UCB | N-020729 DISCN | 1997-06-27 | 3 products |
Hide discontinued
Hydrochlorothiazide
+
Olmesartan medoxomil
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENICAR HCT | Cosette Pharmaceuticals | N-021532 RX | 2003-06-05 | 3 products, RLD, RS |
Hydrochlorothiazide
+
Pindolol
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VISKAZIDE | Novartis | N-018872 DISCN | 1987-07-22 | 2 products |
Hide discontinued
Hydrochlorothiazide
+
Propranolol hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INDERIDE LA 80/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE LA 120/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE LA 160/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE-40/25 | WYETH PHARMS INC | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
INDERIDE-80/25 | WYETH PHARMS INC | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Hydrochlorothiazide
+
Quinapril hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ACCURETIC | Pfizer | N-020125 DISCN | 1999-12-28 | 3 products, RLD |
Hide discontinued
Hydrochlorothiazide
+
Reserpine
Hydrochlorothiazide
+
Spironolactone
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ALDACTAZIDE | Mylan | N-012616 RX | 1982-12-30 | 2 products, RLD, RS |
Hydrochlorothiazide
+
Telmisartan
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MICARDIS HCT | Boehringer Ingelheim | N-021162 RX | 2000-11-17 | 3 products, RLD |
Hydrochlorothiazide
+
Timolol maleate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TIMOLIDE 10-25 | Merck KGaA | N-018061 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydrochlorothiazide
+
Triamterene
Hydrochlorothiazide
+
Valsartan
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DIOVAN HCT | Novartis | N-020818 RX | 1998-03-06 | 5 products, RLD |
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
accuretic | New Drug Application | 2021-12-06 |
aldactazide | New Drug Application | 2021-11-15 |
atacand | New Drug Application | 2020-06-19 |
avalide | New Drug Application | 2021-11-16 |
benicar | New Drug Application | 2022-06-20 |
diovan | New Drug Application | 2022-03-09 |
exforge hct | New Drug Application | 2022-03-09 |
hyzaar | New Drug Application | 2021-06-01 |
irbesartan and hydrochlorothiazide | ANDA | 2023-05-08 |
lopressor | New Drug Application | 2021-01-26 |
Show 11 more
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
edema | — | D004487 | R60.9 |
heart failure | EFO_0003144 | D006333 | I50 |
hypertension | EFO_0000537 | D006973 | I10 |
nephrotic syndrome | EFO_0004255 | D009404 | N04 |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Aliskiren Hemifumarate / Hydrochlorothiazide, Tekturna Hct, Noden Pharma | |||
8618172 | 2028-07-13 | DP | |
Amlodipine Besylate / Hydrochlorothiazide / Valsartan, Exforge Hct, Novartis | |||
8101599 | 2023-05-16 | DP | |
8475839 | 2023-05-16 | DP | |
Aliskiren Hemifumarate / Amlodipine Besylate / Hydrochlorothiazide, Amturnide, Novartis | |||
8183295 | 2023-05-16 | DP |
ATC Codes
C: Cardiovascular system drugs
— C03: Diuretics
— C03A: Low-ceiling diuretics, thiazides
— C03AA: Thiazides, plain
— C03AA03: Hydrochlorothiazide
— C03AB: Thiazides and potassium in combination
— C03AB03: Hydrochlorothiazide and potassium
— C03AX: Thiazides, combinations with other drugs
— C03AX01: Hydrochlorothiazide, combinations
— C03E: Diuretics and potassium-sparing agents in combination
— C03EA: Low-ceiling diuretics and potassium-sparing agents
— C03EA01: Hydrochlorothiazide and potassium-sparing agents
— C09: Agents acting on the renin-angiotensin system
— C09B: Ace inhibitors, combinations
— C09BX: Ace inhibitors, other combinations in atc
— C09BX03: Ramipril, amlodipine and hydrochlorothiazide
— C09D: Angiotensin ii receptor blockers (arbs), combinations
— C09DX: Angiotensin ii receptor blockers (arbs), other combinations
— C09DX01: Valsartan, amlodipine and hydrochlorothiazide
— C09DX03: Olmesartan medoxomil, amlodipine and hydrochlorothiazide
— C09DX06: Candesartan, amlodipine and hydrochlorothiazide
— C09DX07: Irbesartan, amlodipine and hydrochlorothiazide
— C09X: Other agents acting on the renin-angiotensin system in atc
— C09XA: Renin-inhibitors
— C09XA52: Aliskiren and hydrochlorothiazide
— C09XA54: Aliskiren, amlodipine and hydrochlorothiazide
HCPCS
No data
Clinical
Clinical Trials
1425 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 52 | 39 | 215 | 241 | 96 | 636 |
Healthy volunteers/patients | — | 118 | 1 | 1 | 2 | 13 | 135 | ||
Heart failure | D006333 | EFO_0003144 | I50 | 3 | 15 | 26 | 40 | 27 | 107 |
Essential hypertension | D000075222 | I10 | 8 | 15 | 41 | 19 | 4 | 84 | |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 12 | 6 | 11 | 28 | 4 | 58 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 1 | 2 | 8 | 9 | 9 | 28 |
Chronic renal insufficiency | D051436 | N18 | 3 | 1 | 3 | 15 | 2 | 23 | |
Metabolic syndrome | D024821 | EFO_0000195 | E88.81 | 3 | 2 | 6 | 12 | — | 23 |
Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | 10 | 1 | 7 | 1 | 3 | 22 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | 4 | 7 | 7 | 2 | 20 |
Show 114 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypercholesterolemia | D006937 | HP_0003124 | — | — | 6 | — | — | 6 | |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | 2 | 3 | — | 2 | 6 |
Cognitive dysfunction | D060825 | G31.84 | — | 3 | 2 | — | — | 5 | |
Cerebral hemorrhage | D002543 | — | — | 2 | — | 2 | 4 | ||
Aortic valve stenosis | D001024 | EFO_0000266 | Q25.1 | — | 1 | 3 | — | — | 3 |
Nephrolithiasis | D053040 | N20.0 | — | 1 | 2 | — | 1 | 3 | |
Heart arrest | D006323 | EFO_0009492 | I46 | — | 1 | 2 | — | — | 3 |
Ventricular tachycardia | D017180 | I47.2 | — | 2 | 1 | — | 1 | 3 | |
Vascular dementia | D015140 | F01 | — | — | 1 | — | 1 | 2 | |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | 2 | — | — | 2 |
Show 28 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diastolic heart failure | D054144 | EFO_1000899 | I50.30 | — | 1 | — | — | 2 | 3 |
Atrial remodeling | D064752 | — | 1 | — | — | 1 | 2 | ||
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | 2 | 1 | — | — | — | 2 |
Aging | D000375 | GO_0007568 | R41.81 | — | 1 | — | — | 1 | 2 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 2 | — | — | — | 2 |
Cardio-renal syndrome | D059347 | 1 | 1 | — | — | 1 | 2 | ||
Hereditary nephritis | D009394 | EFO_0004128 | Q87.81 | — | 2 | — | — | — | 2 |
Macular edema | D008269 | 1 | 2 | — | — | — | 2 | ||
Myositis | D009220 | EFO_0000783 | G72.49 | — | 1 | — | — | — | 1 |
Fibrosis | D005355 | — | 1 | — | — | — | 1 |
Show 20 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Therapeutic equivalency | D013810 | 5 | — | — | — | — | 5 | ||
Morbid obesity | D009767 | EFO_0001074 | 1 | — | — | — | 4 | 5 | |
Fasting | D005215 | EFO_0002756 | 4 | — | — | — | — | 4 | |
Pharmacokinetics | D010599 | 2 | — | — | — | 1 | 3 | ||
Vascular stiffness | D059289 | 1 | — | — | — | 1 | 2 | ||
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 2 | — | — | — | — | 2 |
Tachycardia | D013610 | HP_0001649 | R00.0 | 1 | — | — | — | 1 | 2 |
Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | — | 1 |
Magnetic resonance imaging | D008279 | 1 | — | — | — | — | 1 | ||
Oral administration | D000284 | 1 | — | — | — | — | 1 |
Show 9 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Percutaneous coronary intervention | D062645 | — | — | — | — | 2 | 2 | ||
Frailty | D000073496 | R53.1 | — | — | — | — | 1 | 1 | |
Hyperaldosteronism | D006929 | HP_0011736 | E26 | — | — | — | — | 1 | 1 |
Headache | D006261 | HP_0002315 | R51 | — | — | — | — | 1 | 1 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | — | 1 | 1 | ||
Coronary occlusion | D054059 | I21 | — | — | — | — | 1 | 1 | |
Drug-eluting stents | D054855 | — | — | — | — | 1 | 1 | ||
Ambulatory blood pressure monitoring | D018660 | — | — | — | — | 1 | 1 | ||
Hiv | D006678 | O98.7 | — | — | — | — | 1 | 1 | |
Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 1 | 1 |
Show 23 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | HYDROCHLOROTHIAZIDE |
INN | hydrochlorothiazide |
Description | Hydrochlorothiazide is a benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. It has a role as a xenobiotic, an environmental contaminant, a diuretic and an antihypertensive agent. It is a benzothiadiazine, a sulfonamide and an organochlorine compound. |
Classification | Small molecule |
Drug class | diuretics (thiazide derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O |
Target
Agency Approved
SLC12A3
SLC12A3
Organism
Homo sapiens
Gene name
SLC12A3
Gene synonyms
NCC, TSC
NCBI Gene ID
Protein name
solute carrier family 12 member 3
Protein synonyms
Na-Cl cotransporter, Na-Cl symporter, NaCl electroneutral thiazide-sensitive cotransporter, NCC, sodium-chloride co-transporter, solute carrier family 12 (sodium/chloride transporter), member 3, thiazide-sensitive Na-Cl cotransporter, Thiazide-sensitive sodium-chloride cotransporter
Uniprot ID
Mouse ortholog
Slc12a3 (20497)
solute carrier family 12 member 3 (P59158)
Alternate
No data
Variants
Clinical Variant
Identifier | Target mutation | Effect | Evaluation | Status |
---|---|---|---|---|
VCV000018274 | ADD1, 1378G>T, Gly460Trp | drug response | 2021-03-24 | 2B |
Financial
Atacand - AstraZeneca
$
€
£
₣
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Exforge - Novartis
$
€
£
₣
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Diovan - Novartis
$
€
£
₣
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 28,075 documents
View more details
Safety
Black-box Warning
Black-box warning for: Accuretic, Atacand, Avalide, Benicar, Diovan, Exforge hct, Hyzaar, Irbesartan and hydrochlorothiazide, Lotensin, Micardis hct, Tekturna, Teveten hct, Tribenzor, Valsartan and hydrochlorothiazide, Vaseretic, Zestoretic
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more